secwatch.observer — SEC 8-K summary
======================================

Issuer:     MedMen Enterprises, Inc. (—)
CIK:        0001776932
Form:       8-K
Filed at:   2024-01-24T23:59:59+00:00
Accession:  0001493152-24-003669
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MedMen CEO and Executive Chairman resign; Chief Restructuring Officer appointed
-------------------------------------------------------------------------------

- CEO Ellen Harrison resigned Jan 19, 2024, effective immediately; not due to disagreement with company.
- Executive Chairman Michael Serruya resigned from Board effective Jan 24, 2024; not due to disagreement.
- Board appointed Richard Ormond as Chief Restructuring Officer on Jan 23, 2024.
- Ormond has 20+ years experience in restructuring, cannabis regulations, and commercial litigation.
- No successor named for CEO or Chairman; company in restructuring mode.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1776932/000149315224003669/0001493152-24-003669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1776932/000149315224003669/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-003669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer